The efficacy of ranibizumab treatment in clinical practice in patients with the wet form of age-related macular degeneration. The results of the Czech National Registry

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F15%3A00084535" target="_blank" >RIV/00216224:14110/15:00084535 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/15:10320123 RIV/61989592:15110/15:33157937 RIV/65269705:_____/15:00063565 RIV/00179906:_____/15:10320123 RIV/00098892:_____/15:#0000967
Result on the web
<a href="http://dx.doi.org/10.5507/bp.2015.017" target="_blank" >http://dx.doi.org/10.5507/bp.2015.017</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5507/bp.2015.017" target="_blank" >10.5507/bp.2015.017</a>

Result language
angličtina
Original language name
The efficacy of ranibizumab treatment in clinical practice in patients with the wet form of age-related macular degeneration. The results of the Czech National Registry
Original language description
Aims. The aim of this communication was to evaluate ranibizumab in the treatment of wet age-related macular degeneration. Methods. Anonymised data on treatment efficacy and safety were consecutively entered into the Czech national database. From 01/09/2008 to 25/10/2011, 671 patients/685 eyes treated with ranibizumab monotherapy were entered in the registry. 454 ranibizumab treated eyes and 444 patients were monitored for 12-months. The dependent variable used to monitor disease progression and treatment results was change in visual acuity in the ETDRS (Early Treatment Diabetic Retinopathy Study) chart over time. Results. After 12 months of treatment, a loss of < 15 letters in the ETDRS chart was found in 81.5% of eyes treated with ranibizumab. A gain of >/= 15 letters was found in 9.7% of eyes on ranibizumab.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FF - ENT (ie. ear, nose, throat), ophthalmology, dentistry
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical
Biomedical Papers of the Faculty of Medicine of Palacký University
ISSN
1213-8118
e-ISSN
—
Volume of the periodical
159
Issue of the periodical within the volume
3
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
6
Pages from-to
407-412
UT code for WoS article
000364948100012
EID of the result in the Scopus database
—

Similar results(10)